Cargando…
Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?
Oncolytic viruses (OVs) provide the promise of tumor-selective cytotoxicity coupled with amplification of the therapeutic agent (the virus) in situ within the tumor improving its therapeutic index. Despite this promise, however, single agent-treatments have not been as successful as combination ther...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407364/ https://www.ncbi.nlm.nih.gov/pubmed/37541690 http://dx.doi.org/10.1136/jitc-2022-006518 |